CIPLA launches inhalable insulin for diabetes care
CIPLA has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a convenient option for many adults living with diabetes. The insulin is delivered via an inhaler device using single-use cartridges. This innovation simplifies insulin delivery and addresses challenges faced by patients with daily injections.
#WatchOutFor#StockInNews#FundamentalViews#TrendingSectors#EquityResearch
766 likes·55 comments

















